Viewing Study NCT00082667


Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2026-04-09 @ 4:58 AM
Study NCT ID: NCT00082667
Status: TERMINATED
Last Update Posted: 2013-02-25
First Post: 2004-05-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast
Sponsor: Vanderbilt-Ingram Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None breast cancer in situ View
None ductal breast carcinoma in situ View